Brief: Ocuphire Pharma Inc - On August 10 Entered Into A Common Stock Purchase Agreement With Lincoln Park Capital Fund
Aug 11 (Reuters) - Ocuphire Pharma Inc OCUP.O :
* OCUPHIRE PHARMA INC - ON AUGUST 10 ENTERED INTO A COMMON
STOCK
PURCHASE AGREEMENT WITH LINCOLN PARK CAPITAL FUND, LLC
* OCUPHIRE PHARMA-AGREEMENT PROVIDES CO CAN SELL TO LINCOLN
PARK
UP TO $50 MILLION OF SHARES OF CO'S COMMON STOCK OVER 30-MONTH
TERM OF PURCHASE AGREEMENT
Source: [https://bit.ly/45groPy]
Further company coverage: OCUP.O
Recent news on Opus Genetics
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data